A High Speed Redundant IO Bus for Energy Power Controller System

This paper designs and implements a High Speed Redundant IO Bus for Energy Power Controller System. The physical layer adopts multi-point low-voltage differential signal standard. This bus has the characteristics of high real-time, high throughput and easy expansion. The controller communicates with IO module by A/B bus alternately, monitors link status in real time and collects IO module data. Non real time slots can be used to control non real time messages for IO modules such as time synchronizing and memory monitoring. The controller ARM core runs QNX real-time operating system, and transmits the message needed to communicate with IO modules to the FPGA through DMA. After receiving the message, the FPGA parses the message and automatically fills in the CRC check code and frame end flag at the end of the message. When the FPGA receives the data feedback from the IO module, it performs CRC verification. If the verification passes, it fills the corresponding module receiving buffer. Otherwise, it fills the CRC verification error flag in the register of the corresponding IO module to reduce the load of the arm core.

Study and quantitative assessment of the structural inhomogeneities parameters of composite materials

The possibility of determining the size of the delamination region and the depth of its location in non-metallic multilayer weakly conductive materials using a unique pulsed eddy-current equipment by scanning the sample and registering the region of increasing amplitude of the differential signal has been practically confirmed. The nonstationary thermal and holographic interferometry method is used to obtain information on the shape and size of the bundles. For experimental testing, samples were used made of carbon fiber composite materials with artificially created defects in the structure of the material in the form of delaminations of various sizes and shapes.

A Novel Approach for the Design of Fast-Settling Amplifiers for Biosignal Detection

The most common method used to pick up biomedical signals is through metallic electrodes coupled to the input of high-gain, low-noise amplifiers. Unfortunately, electrodes, amongst other effects, introduce an undesired contact resistance and a contact potential. The contact potential needs to be rejected since it would otherwise cause the saturation of the input stage of the amplifiers, and this is almost always obtained by inserting a simple RC high-pass filter in the input signal path. The contact resistance needs to be estimated to ensure that it does not impair correct measurements. Methods exist for estimating the contact resistance by dynamically modifying the input network configuration, but because of the presence of the input RC filter, long transients are induced any time a switch occurs between different input configurations, so that the measurement time may become unacceptably long. In this paper, we propose a new topology for a DC removal network at the input of the differential signal amplifier that results in an AC filter whose time constant can be continuously changed by means of a control voltage. As such, we can speed up the recovery from transients by setting very short time constants (during the input resistance estimation process) while maintaining the ability to obtain very low cut-in frequencies by setting a much larger time constant during actual measurements. A prototype of the system was built and tested in order to demonstrate the advantage of the approach we propose in terms of reduced measurement time.

Electrical Performances of Package Layout for High Speed Networking and Cloud Computing Application

In the present generation, internet with instant data access brings up the demands of high speed Ethernet. Development of 400G Ethernet is currently underway. There are two common coding schemes: non-return-to-zero (NRZ) and pulse-amplitude modulation 4-Level (PAM4). Because NRZ needs signaling in higher Nyquist frequency, which results in higher channel dependent loss, PAM4 has become a popular solution. In this paper, we use 85 Ohm differential signal to explore a way to improve performance in the aspects of insertion loss, return loss and crosstalk for 112Gbps PAM4 application. A 12 layer substrate with low-loss dielectric of ABF-GL102 is used for the study. We scan the gap size of via pad which contributes the impedance discontinuity thus impacts signal integrity. Die bump and BGA pin assignments are the other two key factors in cause of crosstalk.

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that disproportionally accounts for the majority of breast cancer-related deaths due to the lack of specific targets for effective treatments. In this review, we highlight the complexity of the transforming growth factor-beta family (TGF-β) pathway and discuss how the dysregulation of the TGF-β pathway promotes oncogenic attributes in TNBC, which negatively affects patient prognosis. Moreover, we discuss recent findings highlighting TGF-β inhibition as a potent method to target mesenchymal (CD44+/CD24−) and epithelial (ALDHhigh) cancer stem cell (CSC) populations. CSCs are associated with tumorigenesis, metastasis, relapse, resistance, and diminished patient prognosis; however, due to differential signal pathway enrichment and plasticity, these populations remain difficult to target and persist as a major barrier barring successful therapy. This review highlights the importance of TGF-β as a driver of chemoresistance, radioresistance and reduced patient prognosis in breast cancer and highlights novel treatment strategies which modulate TGF-β, impede cancer progression and reduce the rate of resistance generation via targeting the CSC populations in TNBC and thus reducing tumorigenicity. Potential TGF-β inhibitors targeting based on clinical trials are summarized for further investigation, which may lead to the development of novel therapies to improve TNBC patient prognosis.

Eliminating Diffusion Effects from NMR Logging Data for Enhanced Carbonate Pore Typing

Transverse relaxation (T2) times measured by multi-frequency, multi-gradient nuclear magnetic resonance (NMR) logging tools are affected by diffusion-induced enhanced relaxation which reduces the sensitivity to pore size in slow-relaxing formations such as macroporous carbonates and complicates the integration with zero-gradient core NMR data. We propose a solution for eliminating the diffusion-related uncertainties using intrinsic T2 distributions, obtained by a new inversion-forward modeling-inversion (IFMI) method, for carbonate pore typing applications. The NMR logs presented in this paper are based on data measured at five frequencies where the static magnetic field gradient varies from 26 to 55 G/cm. The high-quality echo signals are processed using a three-step IFMI differential signal analysis approach which nullifies diffusion effects due to the tool gradient and the potentially present internal gradient caused by paramagnetic minerals in the formation. The resulting diffusion-free intrinsic T2 distribution accentuates fine pore size variations and allows better discernment of micro-, meso-, and macropore systems of complex carbonate reservoirs. Multi-frequency NMR data, acquired in multiple wells, were processed and analyzed in several ways. First, apparent T2 distributions were obtained separately for individual frequencies. Discrepancies between the results of different frequencies clearly indicated that in macro- and mesoporous carbonates the diffusion effect is significant even with TE=0.3ms. This leads a peak broadening observed in the apparent T2 spectrum from conventional NMR processing, where echo trains from different frequencies are averaged in time-domain prior to the inversion. With the IFMI processing, individual-frequency echo trains are first pre-processed using a 2D NMR inversion whose results are used to forward model a diffusion-free echo train without prior assumptions on reservoir fluid diffusivity D. A second inversion, applied on the diffusion-free echo train, yields the intrinsic T2 distribution. The intrinsic T2 distribution has a noticeably higher spectral resolution in carbonate formations where diffusion effect is significant. The intrinsic T2 logs are expected to be more consistent with other gradient-free NMR measurements such as core NMR or LWD NMR data sets.

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that disproportionally accounts for the majority of breast cancer-related deaths due to the lack of specific targets for effective treatments. In this review, we highlight the complexity of the transforming growth factor-beta family (TGF-β) pathway and discuss how the dysregulation of the TGF-β pathway promotes oncogenic attributes in TNBC which negatively affects patient prognosis. Moreover, we discuss recent findings highlighting TGF-β inhibition as a potent method to target mesenchymal (CD44+/CD24-) and epithelial (ALDHhigh) cancer stem cell (CSC) populations. CSCs are associated with tumorigenesis, metastasis, relapse, resistance, and diminished patient prognosis; however, due to differential signal pathway enrichment and plasticity, these populations remain difficult to target and persist as a major barrier barring successful therapy. This review highlights the importance of TGF-β as a driver of chemoresistance, radioresistance and reduced patient prognosis in breast cancer and highlights novel treatment strategies which modulate TGF-β, impede cancer progression and reduce the rate of resistance generation via targeting the CSC populations in TNBC and thus reducing tumorigenicity. Potential TGF-β inhibitors targeting based on clinical trials are summarized for further investigation which may lead to the development of novel therapies to improve TNBC patient prognosis.

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that disproportionally accounts for the majority of breast cancer-related deaths due to the lack of specific targets for effective treatments. In this review, we highlight the complexity of the transforming growth factor-beta family (TGF-β) pathway and discuss how the dysregulation of the TGF-β pathway promotes oncogenic attributes in TNBC which negatively affects patient prognosis. Moreover, we discuss recent findings highlighting TGF-β inhibition as a potent method to target mesenchymal (CD44+/CD24-) and epithelial (ALDHhigh) cancer stem cell (CSC) populations. CSCs are associated with tumorigenesis, metastasis, relapse, resistance, and diminished patient prognosis; however, due to differential signal pathway enrichment and plasticity, these popula-tions remain difficult to target and persist as a major barrier barring successful therapy. This review highlights the importance of TGF-β as a driver of chemoresistance, radioresistance and reduced patient prognosis in breast cancer and discusses novel treatment strategies which modulate TGF-β, impede cancer progression and reduce the rate of resistance generation via targeting the CSC populations in TNBC and thus reducing tumorigenicity. Potential TGF-β inhibitors targeting based on clinical trials are summarized for further investigation which may lead to the development of novel therapies to improve TNBC patient prognosis.